References
- Abrams, J. 2009. Zach Lund seeks to rewrite his legacy after Olympic ban. In The New York Times. https://www.nytimes.com/2009/12/19/sports/olympics/19skeleton.html.
- Ashenden, M., C.E. Gough, A. Garnham, C.J. Gore, and K. Sharpe. 2011. ’’Current markers of the athlete blood passport do not flag microdose EPO doping.’’European Journal of Applied Physiology1119: 2307–14.
- Aubel, O., B. Lefevre, J.M. le Goff, and N. Taverna. 2018. ’’Doping risk and career turning points in male elite road cycling (2005-2016.’’Journal of Science & Medicine in Sport2110: 994–98. 10.1016/j.jsams.2018.03.003.
- Aubel, O., B. Lefevre, J.M. le Goff, and N. Taverna. 2019. ’’The team effect on doping in professional male road cycling (2005-2016.’’Scandinavian Journal of Medicine & Science in Sports294: 615–22. 10.1111/sms.13384.
- Benson, D. 2021. Police raid Bahrain victorious hotel at Tour de France. In Cycling News. https://www.cyclingnews.com/news/tom-dumoulin-puts-career-on-hold-and-leaves-jumbo-visma-training-camp/.
- Bhasin, S., T.W. Storer, N. Berman, C. Callegari, B. Clevenger, J. Phillips, T.J. Bunnell, R. Tricker, A. Shirazi, and R. Casaburi. 1996. ’’The effects of supraphysiological doses of testosterone on muscle size and strength in normal men.’’The New England Journal of Medicine3351: 1–7.
- Birkhoff, W.A.J., J.A.A.C. Heuberger, T.E. Post, P. Gal, F.E. Stuurman, J. Burggraaf, and A.F. Cohen. 2018. ’’Recombinant human erythropoietin does not affect several microvascular parameters in well-trained cyclists.’’Physiological Reports624: e13924. 10.14814/phy2.13924.
- Brewer, B.D. 2002. ’’Commercialization in professional cycling.’’Sociology of Sport Journal193: 276–301.
- Brissonneau, C. and F. Ohl. 2010. ’’The genesis and effect of French anti-doping policies in cycling.’’International Journal of Sport Policy & Politics22: 173–87. 10.1080/19406940.2010.488063.
- Brown, R.C. 2013. ’’Moral responsibility for (un)healthy behaviour.’’Journal of Medical Ethics3911: 695–98. 10.1136/medethics-2012-100774.
- Brown, R.C.H. and J. Savulescu. 2019. ’’Responsibility in healthcare across time and agents.’’Journal of Medical Ethics4510: 636–44. 10.1136/medethics-2019-105382.
- Davies, M.A.M., A.D. Judge, A. Delmestri, S.P.T. Kemp, K.A. Stokes, N.K. Arden, and J.L. Newton. 2017. ’’Health amongst former rugby union players: A cross-sectional study of morbidity and health-related quality of life.’’Scientific Reports71: 11786. 10.1038/s41598-017-12130-y.
- de Hon, O., H. Kuipers, and M. van Bottenburg. 2015. ’’Prevalence of doping use in elite sports: A review of numbers and methods.’’Sports Medicine451: 57–69. 10.1007/s40279-014-0247-x.
- Dundas, C. 2019. Enforcement vs. Enhancement: MMA world still split on anti-doping. In The Athletic. https://theathletic.com/1138304/2019/08/14/enforcement-vs-enhancement-mma-world-still-split-on-anti-doping/.
- Felix, S. and P. Portugal. 2017. ’’Drug decriminalization and the price of illicit drugs.’’International Journal of Drug Policy39: 121–29.
- Fincoeur, B., M. Frenger, and W. Pitsch. 2013. ’’Does one play with the athletes’ health in the name of ethics?’’Performance Enhancement & Health24: 182–93. 10.1016/j.peh.2014.08.002.
- Fincoeur, B., K. van de Ven, and K.J.D. Mulrooney. 2014. ’’The symbiotic evolution of anti-doping and supply chains of doping substances: How criminal networks may benefit from anti-doping policy.’’Trends in Organized Crime183: 229–50. 10.1007/s12117-014-9235-7.
- Geeraets, V. 2017. ’’Ideology, doping and the spirit of sport.’’Sport, Ethics & Philosophy123: 255–71. 10.1080/17511321.2017.1351483.
- Gordon, A. 2017. ’’How does WADA decide what drugs are banned?.’’ In Vice. https://www.vice.com/en_us/article/8xavbp/how-does-wada-decide-what-drugs-are-banned
- Hall, T. 2008. ’’Doing harm, allowing harm, and denying resources.’’Journal of Moral Philosophy51: 50–76. 10.1163/174552408x306726.
- Hardeman, M., T. Alexy, B. Brouwer, P. Connes, F. Jung, H. Kuipers, and O.K. Baskurt. 2014. ’’EPO or PlacEPO? Science versus practical experience: Panel discussion on efficacy of erythropoetin in improving performance.’’Biorheology512–3: 83–90. 10.3233/BIR-140655.
- Henning, A. 2017. ’’Challenges to promoting health for amateur athletes through anti-doping policy.’’Drugs: Education, Prevention & Policy243: 306–13. 10.1080/09687637.2016.1208732.
- Henning, A.D. and P. Dimeo. 2018. ’’The new front in the war on doping: Amateur athletes.’’ International Journal of Drug Policy51: 128–36. 10.1016/j.drugpo.2017.05.036.
- Henning, A. and P. Dimeo. 2022. ’’Doping: A sporting history.’’ London, UK. Reaktion Books Ltd.
- Henning, A., K. McLean, J. Andreasson, and P. Dimeo. 2021. ’’Risk and enabling environments in sport: Systematic doping as harm reduction.’’ International Journal of Drug Policy91: 102897. 10.1016/j.drugpo.2020.102897.
- Heuberger, J.A. and A.F. Cohen. 2019. ’’Review of WADA prohibited substances: Limited evidence for performance-enhancing effects.’’Sports Medicine494: 525–39. 10.1007/s40279-018-1014-1.
- Heuberger, J.A.A.C., A. Henning, A.F. Cohen, and B. Kayser. 2022. ’’Dealing with doping. A plea for better science, governance and education.’’British Journal of Clinical Pharmacology882: 566–78. 10.1111/bcp.14998.
- Heuberger, J.A.A.C., J.I. Rotmans, P. Gal, F.E. Stuurman, J. van ‘T Westende, T.E. Post, J.M.A. Daniels, M. Moerland, P.L.J. van Veldhoven, M.L. de Kam, H. Ram, O.de Hon, J.J. Posthuman, J. Burggraaf, and A.F. Cohen 2017. ’’Effects of erythropoietin on cycling performance of well trained cyclists: A double-blind, randomised, placebo-controlled trial.’’ The Lancet Haematology 4 (8): e374–e86. 10.1016/s2352-3026(17)30105-9
- Horwitz, H., J.T. Andersen, and K.P. Dalhoff. 2019. ’’Health consequences of androgenic anabolic steroid use.’’Journal of Internal Medicine2853: 333–40. 10.1111/joim.12850.
- House of Commons. 2018. Combatting doping in sport. London: House of Commons. https://publications.parliament.uk/pa/cm201719/cmselect/cmcumeds/366/36602.htm
- Hughes, C.E. and A. Stevens. 2012. ’’A resounding success or a disastrous failure: Re-examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs.’’Drug & Alcohol Review311: 101–13. 10.1111/j.1465-3362.2011.00383.x.
- IOC. 1999. Lausanne declaration on doping in sport. In. https://www.wada-ama.org/sites/default/files/resources/files/lausanne_declaration_on_doping_in_sport.pdf.
- Jedlicka, S.R. and T.M. Hunt. 2013. ’’The international anti-doping movement and UNESCO: A historical case study.’’The International Journal of the History of Sport3013: 1523–35. 10.1080/09523367.2013.823404.
- Kayser, B. and B. Broers. 2012. ’’The Olympics and harm reduction?’’ Harm Reduction Journal9: 33. 10.1186/1477-7517-9-33.
- Kayser, B. and A. de Block. 2020. ’’Would relaxation of the anti-doping rule lead to red queen effects?’’Sport, Ethics & Philosophy153: 371–85. 10.1080/17511321.2020.1770846.
- Kettunen, J.A., U.M. Kujala, J. Kaprio, H. Backmand, M. Peltonen, J.G. Eriksson, and S. Sarna. 2015. ’’All-cause and disease-specific mortality among male, former elite athletes: An average 50-year follow-up.’’British Journal of Sports Medicine4913: 893–97. 10.1136/bjsports-2013-093347.
- Kontro, T.K., S. Sarna, J. Kaprio, and U.M. Kujala. 2017. ’’Use of alcohol and alcohol-related morbidity in Finnish former elite athletes.’’Medicine & Science in Sports and Exercise493: 492–99. 10.1249/MSS.0000000000001137.
- Kontro, T.K., S. Sarna, J. Kaprio, and U.M. Kujala. 2018. ’’Mortality and health-related habits in 900 Finnish former elite athletes and their brothers.’’British Journal of Sports Medicine522: 89–95. 10.1136/bjsports-2017-098206.
- Lemez, S. and J. Baker. 2015. ’’Do elite athletes live longer? A systematic review of mortality and longevity in elite athletes.’’Sports Medicine Open11: 16. 10.1186/s40798-015-0024-x.
- Lindqvist, A.S., T. Moberg, C. Ehrnborg, B.O. Eriksson, C. Fahlke, and T. Rosen. 2014. ’’Increased mortality rate and suicide in Swedish former elite male athletes in power sports.’’Scandinavian Journal of Medicine & Science in Sports246: 1000–05. 10.1111/sms.12122.
- Lodewijkx, H.F.M. 2013. ’’The epo fable in professional cycling: Facts, fallacies and fabrications.’’ Journal of Sports Medicine & Doping Studies403: 10.4172/2161-0673.1000141.
- Lodewijkx, H.F. and B. Brouwer. 2011. ’’Some empirical notes on the EPO epidemic in professional cycling.’’Research Quarterly for Exercise & Sport824: 740–54. 10.1080/02701367.2011.10599811.
- Marijon, E., M. Tafflet, J. Antero-jacquemin, N. el Helou, G. Berthelot, D.S. Celermajer, and W. Bougouin et al. 2013. ’’Mortality of French participants in the tour de France (1947-2012.’’ European Heart Journal3440: 3145–50. 10.1093/eurheartj/eht347
- Marrocco, S. 2019. T.J. Dillashaw explains reason for EPO use_ ‘I’m not mad I did it’. Accessed March 9. https://mmajunkie.usatoday.com/2019/06/tj-dillashaw-explains-why-he-used-epo-chael-sonnen-admits-took-same-drug-bellator-ufc-usada.
- McBride, J.A., C.C. Carson 3rd, and R.M. Coward. 2018. ’’The Availability and Acquisition of Illicit Anabolic Androgenic Steroids and Testosterone Preparations on the Internet.’’American Journal of Men’s Health125: 1352–57. 10.1177/1557988316648704.
- McMahan, J. 1993. ’’Killing, letting die, and withdrawing aid.’’Ethics103: 250–79.
- Milot, L. 2014. ’’Ignorance, harm, and the regulation of performance-enhancing substances.’’Harvard Journal of Sports and Entertainment Law5: 91–146.
- Moore, E. and J. Morrison. 2022. ’’In defense of medically supervised doping.’’Journal of the Philosophy of Sport492: 159–76. 10.1080/00948705.2022.2066538.
- Morrison, J. 2023. ’’Lack of evidence that doping is harmful to the health of elite athletes.’’ Performance Enhancement & Health111: 10.1016/j.peh.2023.100245.
- o’hare, P. 2007. ’’Merseyside, the first harm reduction conferences, and the early history of harm reduction.’’International Journal of Drug Policy182: 141–44.
- Petroczi, A., M. Cruyff, O. de Hon, D. Sagoe, and M. Saugy. 2022. ’’Hidden figures: Revisiting doping prevalence estimates previously reported for two major international sport events in the context of further empirical evidence and the extant literature.’’ Frontiers in Sport and Active Living4: 1017329. 10.3389/fspor.2022.1017329.
- Pugh, J., C. Pugh, and J. Savulescu. 2017. ’’Exercise prescription and the doctor’s duty of non-maleficence.’’British Journal of Sports Medicine5121: 1555–56. 10.1136/bjsports-2016-097388.
- Rasmussen, K. 2006. ’’The quest for the imaginary evil: A critique of anti-doping.’’Sport in History253: 515–35. 10.1080/17460260500396426.
- Roe, G. 2005. ’’Harm reduction as paradigm: Is better than bad good enough? The origins of harm reduction.’’Critical Public Health153: 243–50.
- Rohan, T. 2013. Antidoping agency delays publication of research. In The New York Times. https://www.nytimes.com/2013/08/23/sports/research-finds-wide-doping-study-withheld.html?_r=0.
- Rudy-Hiller, F. 2018. ’’The epistemic condition for moral responsibility.’’ Stanford Encyclopedia of Philosophy (Fall 2018 Edition) https://plato.stanford.edu/archives/fall2018/entries/moral-responsibility-epistemic/
- Russoniello, K. 2012. ’’The devil (and drugs) in the details: Portugal’s focus on public health as a model for decriminalization of drugs in Mexico.’’Yale Journal of Health Policy, Law, and Ethics122: 371–431.
- Sanchis-gomar, F., G. Olaso-gonzalez, D. Corella, M.C. Gomez-cabrera, and J. Vina. 2011. ’’Increased average longevity among the “Tour de France” cyclists.’’International Journal of Sports Medicine328: 644–47. 10.1055/s-0031-1271711.
- Teetzel, S. 2007. ’’Respecting privacy in detecting illegitimate enhancements in athletes.’’Sport, Ethics & Philosophy12: 159–70. 10.1080/17511320701425371.
- Ulrich, R., H.G. Pope, L. Cleret, A. Petroczi, T. Nepusz, J. Schaffer, G. Kanayama, R.D. Comstock, and P. Simon. 2018. ’’Doping in two elite athletics competitions assessed by randomized-response surveys.’’Sports Medicine481: 211–19. 10.1007/s40279-017-0765-4.
- USADA.2012. ’’US postal service pro cycling team investigation.’’ USADA. https://www.usada.org/athletes/results/u-s-postal-service-pro-cycling-team-investigation/.
- USADA. 2012. Statement from USADA CEO Travis T. Tygart regarding the U.S. Postal service pro cycling team doping conspiracy. In. https://www.usada.org/statement/statement-from-usada-ceo-travis-t-tygart-regarding-the-u-s-postal-service-pro-cycling-team-doping-conspiracy/: USADA.org.
- Vale de Andrade, P. and L. Carapinha. 2010. ’’Drug decriminalisation in Portugal.’’ BMJ341: c4554. 10.1136/bmj.c4554.
- WADA. 2020. The World Anti-Doping Code. World Anti-Doping Agency. https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf:.
- Waddington, I. and V. Møller. 2019. ’’WADA at twenty: Old problems and old thinking?’’International Journal of Sport Policy & Politics112: 219–31. 10.1080/19406940.2019.1581645.
- WMA. 2021. World Medical Association declaration on principles of health care for sports medicine. https://www.wma.net/policies-post/wma-declaration-on-principles-of-health-care-for-sports-medicine/.
- Woollard, F. and F. Howard-Snyder. 2022. ’’Doing vs. Allowing harm.’’ Stanford Encyclopedia of Philosophy (Winter 2022 Edition). https://plato.stanford.edu/archives/win2022/entries/doing-allowing/.